← Back to Search
Insight Into Tubulin Regulation From A Complex With Colchicine And A Stathmin-like Domain
R. Ravelli, B. Gigant, P. Curmi, I. Jourdain, S. Lachkar, A. Sobel, Marcel Knossow
Published 2004 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Microtubules are cytoskeletal polymers of tubulin involved in many cellular functions. Their dynamic instability is controlled by numerous compounds and proteins, including colchicine and stathmin family proteins. The way in which microtubule instability is regulated at the molecular level has remained elusive, mainly because of the lack of appropriate structural data. Here, we present the structure, at 3.5 Å resolution, of tubulin in complex with colchicine and with the stathmin-like domain (SLD) of RB3. It shows the interaction of RB3-SLD with two tubulin heterodimers in a curved complex capped by the SLD amino-terminal domain, which prevents the incorporation of the complexed tubulin into microtubules. A comparison with the structure of tubulin in protofilaments shows changes in the subunits of tubulin as it switches from its straight conformation to a curved one. These changes correlate with the loss of lateral contacts and provide a rationale for the rapid microtubule depolymerization characteristic of dynamic instability. Moreover, the tubulin–colchicine complex sheds light on the mechanism of colchicine's activity: we show that colchicine binds at a location where it prevents curved tubulin from adopting a straight structure, which inhibits assembly.
This paper references
The colchicine-binding protein of mammalian brain and its relation to microtubules.
R. Weisenberg (1968)
Interaction of drugs with microtubule proteins.
L. Wilson (1974)
Dominoes and clocks: the union of two views of the cell cycle.
A. Murray (1989)
Cell cycle extracts.
A. Murray (1991)
Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product
W. Kaelin (1991)
Interactions of colchicine with tubulin.
S. Hastie (1991)
Analysis of the colchicine‐binding site of β‐tubulin
R. Burns (1992)
Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes.
D. Skoufias (1992)
Stathmin gene family: phylogenetic conservation and developmental regulation in Xenopus.
A. Maucuer (1993)
Multiple phosphorylation of stathmin
Laura Carola Beretta (1993)
Effect of colchicine analogues on the dissociation of alpha beta tubulin into subunits: the locus of colchicine binding.
K. E. Shearwin (1994)
pl9 skp1 and p45 skp2 are essential elements of the cyclin A-CDK2 S phase kinase
Hui Zhang (1995)
Kinetic stabilization of microtubule dynamics at steady state in vitro by substoichiometric concentrations of tubulin-colchicine complex.
D. Panda (1995)
Identification of a Protein That Interacts with Tubulin Dimers and Increases the Catastrophe Rate of Microtubules
L. Belmont (1996)
Direct Observation of Protein Solvation and Discrete Disorder with Experimental Crystallographic Phases
F. T. Burling (1996)
Stathmin: a tubulin-sequestering protein which forms a ternary T2S complex with two tubulin molecules.
L. Jourdain (1997)
The stathmin tubulin interaction in vitro
P. A. Curmi (1997)
The CCP 4 Suite — Computer programs for protein crystallography
L. Lally (1998)
Geminin, an Inhibitor of DNA Replication, Is Degraded during Mitosis
T. McGarry (1998)
Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1.
G. Fang (1998)
Tubulin and FtsZ form a distinct family of GTPases
E. Nogales (1998)
Crystal structure of the bacterial cell-division protein FtsZ
J. Löwe (1998)
Structural changes at microtubule ends accompanying GTP hydrolysis: Information from a slowly hydrolyzable analogue of GTP, guanylyl (α,β)methylenediphosphonate
T. Müller-Reichert (1998)
Whose end is destruction: cell division and the anaphase-promoting complex.
W. Zachariae (1999)
High-Resolution Model of the Microtubule
E. Nogales (1999)
Nonperiodic Activity of the Human Anaphase-Promoting Complex–Cdh1 Ubiquitin Ligase Results in Continuous DNA Synthesis Uncoupled from Mitosis
C. Sørensen (2000)
Mapping the binding site of colchicinoids on beta -tubulin. 2-Chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354.
R. Bai (2000)
The 4 Å X-Ray Structure of a Tubulin:Stathmin-like Domain Complex
B. Gigant (2000)
The F‐box protein Skp2 is a ubiquitylation target of a Cul1‐based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts
Christiane Wirbelauer (2000)
The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.
C. Pfleger (2000)
Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication
K. Nakayama (2000)
Op18/stathmin caps a kinked protofilament‐like tubulin tetramer
M. Steinmetz (2000)
The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction.
Y. Wan (2001)
Role of the F-box protein Skp2 in lymphomagenesis
E. Latres (2001)
Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex.
C. Pfleger (2001)
Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2
C. Nelsen (2001)
Yeast Hct1 recognizes the mitotic cyclin Clb2 and other substrates of the ubiquitin ligase APC
M. Schwab (2001)
Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.
K. Nakayama (2001)
Stathmin Family Proteins Display Specific Molecular and Tubulin Binding Properties*
E. Charbaut (2001)
Skp2 is oncogenic and overexpressed in human cancers
M. Gstaiger (2001)
Use of TLS parameters to model anisotropic displacements in macromolecular refinement.
M. Winn (2001)
Refined structure of alpha beta-tubulin at 3.5 A resolution.
J. Löwe (2001)
A Conserved Cyclin-Binding Domain Determines Functional Interplay between Anaphase-Promoting Complex–Cdh1 and Cyclin A-Cdk2 during Cell Cycle Progression
C. Sørensen (2001)
The anaphase-promoting complex: it's not just for mitosis any more.
J. W. Harper (2002)
The anaphase-promoting complex: proteolysis in mitosis and beyond.
J. Peters (2002)
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
T. Brummelkamp (2002)
The oncoprotein 18/stathmin family of microtubule destabilizers.
L. Cassimeris (2002)
Microtubule structure at 8 A resolution.
H. Li (2002)
A genetic algorithm for the identification of conformationally invariant regions in protein molecules.
T. Schneider (2002)
Tome-1, a Trigger of Mitotic Entry, Is Degraded during G1 via the APC
N. Ayad (2003)
Deregulated degradation of the cdk inhibitor p27 and malignant transformation.
J. Bloom (2003)
Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
H. Imaki (2003)
The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.
N. von der Lehr (2003)
Zero-dose extrapolation as part of macromolecular synchrotron data reduction.
K. Diederichs (2003)
Skp2 regulates Myc protein stability and activity.
S. Kim (2003)
Thermodynamics of the Op18/Stathmin-Tubulin Interaction*
S. Honnappa (2003)
Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase
T. Bashir (2004)
This paper is referenced by
Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis
Zujin Xiang (2021)
Kv7 channel trafficking by the microtubule network in vascular smooth muscle
T. A. Jepps (2021)
Scrutinizing pharmacological efficiency for Acacia auriculiformis by experimental and computational approach
Shafinaz Nur (2021)
Indolyl-α-keto-1,3,4-oxadiazoles: synthesis, anti-cell proliferation activity, and inhibition of tubulin polymerization.
Mukund P. Tantak (2021)
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
J. Tardif (2021)
COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review
K. Nas (2021)
Nanoscopic Structural Fluctuations of Disassembling Microtubules Revealed by Label‐Free Super‐Resolution Microscopy
M. Vala (2021)
New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure–activity relationships, and molecular modelling
Alba Vicente-Blázquez (2021)
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
J. Tardif (2021)
Genetics of symptom remission in outpatients with COVID-19
M. Dubé (2021)
Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect
Jianhong Yang (2021)
Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line
Myriam González (2021)
New Estrone Oxime Derivatives: Synthesis, Cytotoxic Evaluation and Docking Studies
C. Canário (2021)
Preclinical and Early Clinical Development of PTC596, a Novel Small Molecule Tubulin-Binding Agent.
F. Jernigan (2021)
An insight into the anticancer potential of carbamates and thiocarbamates of 10-demethoxy-10-methylaminocolchicine.
Julia Krzywik (2021)
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT
M. Dubé (2021)
Dynamic Microtubule Arrays in Leukocytes and Their Role in Cell Migration and Immune Synapse Formation
Aglaja Kopf (2021)
Identification of novel microtubule inhibitors effective in fission yeast and human cells and their effects on breast cancer cell lines
J. Morishita (2021)
Stiffening of DU145 prostate cancer cells driven by actin filaments - microtubule crosstalk conferring resistance to microtubule-targeting drugs.
Andrzej Kubiak (2021)
Novel chromenyl-based 2-iminothiazolidin-4-one derivatives as tubulin polymerization inhibitors: Design, synthesis, biological evaluation and molecular modelling studies
D. K. Sigalapalli (2021)
The Game of Tubulins
Maria Alvarado Kristensson (2021)
Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial
Tayyab Shah (2021)
Targeting the Achilles Heel of FtsZ: The Interdomain Cleft
Pinkilata Pradhan (2021)
Phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonates and phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonamides as new antimicrotubule agents targeting the colchicine-binding site.
Mathieu Gagné-Boulet (2021)
Colchicine in coronary artery disease
A. Katira (2021)
The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress
M. Albahde (2021)
Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors
Laura Gallego-Yerga (2021)
Biochemical and Histopathological Effects of Colchicine and Moringa oleifera on Thioacetamide-Induced Liver Fibrosis in Rats
R. Emara (2021)
Purification of functional Plasmodium falciparum tubulin allows for the identification of parasite-specific microtubule inhibitors
W. Hirst (2021)
Transmigration of Neutrophils From Patients With Familial Mediterranean Fever Causes Increased Cell Activation
A. Martirosyan (2021)
Discovery of an Indole-Substituted Furanone with Tubulin Polymerization Inhibition Activity.
P. Mowery (2021)
KLF4 Upregulation in Atherosclerotic Thoracic Aortas: Exploring the Protective Effect of Colchicine-based Regimens in a Hyperlipidemic Rabbit Model.
K. Mylonas (2021)See more